Company Filing History:
Years Active: 2003
Title: Innovations by Ming-Hsiu Ho in Biological Sequence Analysis
Introduction
Ming-Hsiu Ho is an accomplished inventor based in San Jose, California, known for his significant contributions to the field of biological sequence analysis. With a total of two patents to his name, he has developed innovative techniques that enhance our understanding of gene expression and nucleic acid behaviors.
Latest Patents
Among his noteworthy inventions, the first patent focuses on computer-aided techniques for analyzing biological sequences. This invention facilitates advanced analysis of hybridization intensities, allowing researchers to determine the hybridization affinity between nucleic acid probes and sample nucleic acid sequences. It provides a robust method for calling bases in sample sequences, with the ability to combine multiple base calls into a single result. Additionally, it enables monitoring of gene expression changes relative to a baseline, offering profound insights into biological processes.
His second patent involves methods and computer software products designed for multiple probe gene expression analysis. This approach utilizes multiple probes across several experiments to determine gene expression levels. By employing principal component analysis, it effectively assesses the relative expression of genes, paving the way for enhanced data interpretation.
Career Highlights
Ming-Hsiu Ho is currently employed at Affymetrix, Inc., a leading company specializing in genetic analysis and sequencing technologies. His work at Affymetrix has allowed him to further innovate and contribute to significant advancements in the field.
Collaborations
In his professional journey, Ming-Hsiu Ho has collaborated with notable coworkers, including Teresa A Webster and MacDonald S Morris. Such collaborations demonstrate his integration within a talented team dedicated to pioneering innovations in biological analysis.
Conclusion
Ming-Hsiu Ho's inventions are pivotal in advancing the techniques used in biological sequence analysis. With his expertise and patents, he continues to make significant contributions to the field, solidifying his role as an innovative leader in genetic research. His work not only benefits academic research but also the broader scientific community.